Explain Limitations of COVID-19 Antibody Testing
November 2020
Point-of-care fingerstick antibody tests for SARS-CoV-2 are entering the scene.
We know these serology tests aim to identify a RECENT or PRIOR infection with COVID-19. The Assure/FaStep COVID-19 IgG/IgM test is the first to have an "emergency use authorization" (EUA) for point-of-care use.
Expect a limited role for antibody testing in the hospital. A positive test doesn't indicate immunity...or allow changes in precautions for COVID-19 (physical distancing, handwashing, mask-wearing, etc).
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote